Brian Shelton
Brian Shelton was the first patient to receive an experimental stem cell therapy for type 1 diabetes in 2021, which successfully cured his severe hypoglycemia episodes. Unfortunately, he passed away shortly after the treatment due to pre-existing dementia symptoms.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Brian Shelton was the first patient to receive the experimental therapy but died shortly after due to pre-existing dementia symptoms.
5
Brazil:
Brian Shelton was the first patient to receive the experimental therapy in 2021.
5